IGF::OT::IGF, THE FIRST ORAL ANTIBIOTIC FOR THE TREATMENT OF ACUTE MELIODOSIS AND SELECT AGENTS" FOR MODIFI…
Award details are derived from public USAspending.gov records. Not a bid recommendation.
Award details
- Award ID
- HDTRA114C0122
- Contractor
- EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.
- Awarding agency
- Department of Defense
- Sub-agency / office
- Defense Threat Reduction Agency
- Award amount
- $16,072,041
- Period of performance
- Jun 8, 2018 – Aug 10, 2019
- NAICS
- 541711 — Research and Development in Biotechnology
- PSC
- PSC AN12
Public award description
IGF::OT::IGF, THE FIRST ORAL ANTIBIOTIC FOR THE TREATMENT OF ACUTE MELIODOSIS AND SELECT AGENTS" FOR MODIFICATIONS P00011, 12 AND 13.
Find out who's winning similar federal contracts
Discover comparable awards, related contractors, and agency purchasing history.